Global Health & Market Dynamics: Key Updates

Current health news includes Rigaku's shares falling after IPO, Dexcom exceeding sales expectations, Lilly's obesity drug launch in Denmark, and an analysis showing weight-loss drugs not reducing health costs. Other updates cover ResMed's profit rise, Universal Health Services' expenses, fast-food chains omitting onions, McDonald's lawsuit, bird flu cases in California, and a major UnitedHealth data breach.

In recent health news, the shares of Rigaku experienced an 11% slump following their IPO launch, influenced by Carlyle Group's oversight and a high-priced offering. Dexcom, however, surpassed Wall Street's financial expectations with its continuous glucose monitor sales, even though future forecasts led to a 20% drop in share value post-announcement.

Eli Lilly's entry into Denmark's competitive market with its innovative obesity drug marks a significant stride against Novo Nordisk's dominance. Despite the promise of these treatments, research suggests they fail to decrease health costs, according to claims analyzed by Reuters.

Meanwhile, fast-food giants have eliminated onions from menus due to an E. coli outbreak, McDonald's faces legal repercussions, and human bird flu cases in California may be underreported due to testing resistance.

(With inputs from agencies.)